Curtiss-Wright (NYSE: CW) director logs 727-share deferred stock award

Rhea-AI Filing Summary

Curtiss-Wright Corporation director Dean M. Flatt reported acquiring additional common stock through deferred director compensation. On January 2, 2026, he acquired 727 shares of Curtiss-Wright common stock at a price of $572.38 per share, recorded as an acquisition. After this transaction, he beneficially owned 12,429 shares directly.

The shares were issued under the company’s 2024 Omnibus Incentive Plan, which allows non-employee directors to defer compensation and receive annual restricted stock awards and fees in stock at a later date. The 727 shares relate to compensation earned in 2018, 2019, 2020, and 2021, with delivery deferred to January 2, 2026, and include dividend credits on outstanding awards.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider FLATT DEAN M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	727	$572.38	$416K

Holdings After Transaction: Common Stock — 12,429 shares (Direct)

Footnotes (1)

1. Shares were acquired through the Corporation's 2024 Omnibus Incentive Plan whereby non-employee directors may elect to defer their compensation, including their annual restricted stock award, and/or receive their annual retainer and meeting fees in the form of stock to a later date. This amount reflects shares that were earned in 2018, 2019, 2020, and 2021, but receipt was deferred to January 2, 2026. Share total represents a percentage of the annual restricted stock award to be received in stock in each of those years as the Reporting Person elected to receive such stock in various equal annual installments beginning on various dates. The number of shares acquired for the annual restricted stock award is calculated based on the value of the award divided by the closing price for the Issuer's common stock as reported by the New York Stock Exchange on the date the Board initially approved the award. The number of shares is rounded up to the nearest whole share and included dividend credits earned on outstanding awards. Price is based on the closing market price for the Issuer's securities on the New York Stock Exchange as of January 2, 2026. The date recipient elected to receive his shares.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FLATT DEAN M

(Last) (First) (Middle)

C/O CURTISS-WRIGHT CORPORATION

130 HARBOUR PLACE DRIVE

(Street)

DAVIDSON NC 28036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CURTISS WRIGHT CORP [ CW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/02/2026		A(1)		727(2)	A	$572.38(3)	12,429	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares were acquired through the Corporation's 2024 Omnibus Incentive Plan whereby non-employee directors may elect to defer their compensation, including their annual restricted stock award, and/or receive their annual retainer and meeting fees in the form of stock to a later date.

2. This amount reflects shares that were earned in 2018, 2019, 2020, and 2021, but receipt was deferred to January 2, 2026. Share total represents a percentage of the annual restricted stock award to be received in stock in each of those years as the Reporting Person elected to receive such stock in various equal annual installments beginning on various dates. The number of shares acquired for the annual restricted stock award is calculated based on the value of the award divided by the closing price for the Issuer's common stock as reported by the New York Stock Exchange on the date the Board initially approved the award. The number of shares is rounded up to the nearest whole share and included dividend credits earned on outstanding awards.

3. Price is based on the closing market price for the Issuer's securities on the New York Stock Exchange as of January 2, 2026. The date recipient elected to receive his shares.

Remarks:

	George P. McDonald by Power of Attorney for Dean M. Flatt	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Curtiss-Wright (CW) report in this Form 4?

The filing reports that director Dean M. Flatt acquired 727 shares of Curtiss-Wright common stock on January 2, 2026, recorded as an acquisition under Table I.

At what price were the Curtiss-Wright (CW) shares acquired in this transaction?

The 727 shares were acquired at a price of $572.38 per share, based on the closing market price for Curtiss-Wright common stock on the New York Stock Exchange as of January 2, 2026.

How many Curtiss-Wright (CW) shares does the reporting person own after this transaction?

Following the reported acquisition, director Dean M. Flatt beneficially owned 12,429 shares of Curtiss-Wright common stock, held with direct ownership.

What plan was used for the Curtiss-Wright (CW) director’s share acquisition?

The shares were issued under Curtiss-Wright’s 2024 Omnibus Incentive Plan, which allows non-employee directors to defer their compensation and receive annual restricted stock awards and fees in the form of stock at a later date.

Which years’ compensation does the 727-share Curtiss-Wright (CW) award relate to?

The 727 shares reflect stock earned in 2018, 2019, 2020, and 2021, for which the director elected to defer receipt until January 2, 2026, in various equal annual installments.

Does this Curtiss-Wright (CW) Form 4 report any derivative securities?

No. Table II for derivative securities is included in the form layout, but there are no derivative securities reported as acquired, disposed of, or beneficially owned in this filing.